Free Trial
→ Tomorrow morning's stock alert (From The Early Bird) (Ad)tc pixel Free TVGNW Stock Alerts

Tevogen Bio (TVGNW) Competitors

Tevogen Bio logo
$0.04 0.00 (-4.78%)
As of 11:22 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

TVGNW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy Tevogen Bio stock or one of its competitors? MarketBeat compares Tevogen Bio with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tevogen Bio include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does Tevogen Bio compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Tevogen Bio (NASDAQ:TVGNW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
Tevogen BioN/AN/AN/AN/AN/A

In the previous week, Tevogen Bio had 1 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 1 mentions for Tevogen Bio and 0 mentions for 60 Degrees Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Tevogen Bio'saverage media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
Tevogen Bio Neutral

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Tevogen Bio N/A N/A N/A

Summary

60 Degrees Pharmaceuticals and Tevogen Bio tied by winning 1 of the 2 factors compared between the two stocks.

How does Tevogen Bio compare to Alpha Tau Medical?

Tevogen Bio (NASDAQ:TVGNW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tevogen BioN/AN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

In the previous week, Tevogen Bio had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 1 mentions for Tevogen Bio and 0 mentions for Alpha Tau Medical. Tevogen Bio's average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
Tevogen Bio Neutral
Alpha Tau Medical Neutral

Company Net Margins Return on Equity Return on Assets
Tevogen BioN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

Summary

Tevogen Bio beats Alpha Tau Medical on 1 of the 1 factors compared between the two stocks.

How does Tevogen Bio compare to Apollomics?

Apollomics (NASDAQ:APLMW) and Tevogen Bio (NASDAQ:TVGNW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

In the previous week, Tevogen Bio had 1 more articles in the media than Apollomics. MarketBeat recorded 1 mentions for Tevogen Bio and 0 mentions for Apollomics. Apollomics' average media sentiment score of 0.00 equaled Tevogen Bio'saverage media sentiment score.

Company Overall Sentiment
Apollomics Neutral
Tevogen Bio Neutral

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Tevogen Bio N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
Tevogen BioN/AN/AN/AN/AN/A

Summary

Apollomics and Tevogen Bio tied by winning 1 of the 2 factors compared between the two stocks.

How does Tevogen Bio compare to BioVie?

BioVie (NASDAQ:BIVIW) and Tevogen Bio (NASDAQ:TVGNW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Tevogen BioN/AN/AN/AN/AN/A

In the previous week, Tevogen Bio had 1 more articles in the media than BioVie. MarketBeat recorded 1 mentions for Tevogen Bio and 0 mentions for BioVie. BioVie's average media sentiment score of 0.00 equaled Tevogen Bio'saverage media sentiment score.

Company Overall Sentiment
BioVie Neutral
Tevogen Bio Neutral

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Tevogen Bio N/A N/A N/A

Summary

Tevogen Bio beats BioVie on 1 of the 1 factors compared between the two stocks.

How does Tevogen Bio compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and Tevogen Bio (NASDAQ:TVGNW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.

In the previous week, Tevogen Bio had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 1 mentions for Tevogen Bio and 0 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 0.00 equaled Tevogen Bio'saverage media sentiment score.

Company Overall Sentiment
Cardio Diagnostics Neutral
Tevogen Bio Neutral

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
Tevogen Bio N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
Tevogen BioN/AN/AN/AN/AN/A

Summary

Cardio Diagnostics and Tevogen Bio tied by winning 1 of the 2 factors compared between the two stocks.

Get Tevogen Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TVGNW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TVGNW vs. The Competition

Export
MetricTevogen BioBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$475.47M$6.37B$12.45B
Dividend YieldN/A3.86%2.76%5.27%
P/E RatioN/A3.3920.8525.83
Price / SalesN/A6,887.07513.2769.35
Price / CashN/A13.1343.4956.67
Price / BookN/A85.4710.437.12
Net IncomeN/A-$96.07M$3.56B$336.98M
7 Day PerformanceN/A1.01%2.96%3.29%
1 Month PerformanceN/A1.58%2.39%3.38%
1 Year PerformanceN/A82.27%36.28%36.21%

Tevogen Bio Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TVGNW
Tevogen Bio
N/A$0.04
-4.8%		N/A-46.3%$0.00N/AN/A17
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
-22.4%		N/AN/A$0.00$1.01MN/A2
DRTSW
Alpha Tau Medical
N/A$2.15
+7.8%		N/AN/A$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
-17.0%		N/A-34.4%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.30
+10.9%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:TVGNW) was last updated on 5/27/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel